Advertisement

Topics

Asahi Kasei Pharma Corp. Company Profile

01:41 EDT 19th October 2017 | BioPortfolio

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients throughout the world. www.akpamerica.com


News Articles [692 Associated News Articles listed on BioPortfolio]

Bone Therapeutics SA et Asahi Kasei signent un accord de licence exclusive portant sur PREOB® au Japon

Bone Therapeutics SA — Friday, September 22nd 2017 at 5:00am UTC Information réglementée Bone Therapeutics et Asahi Kasei signent un accord de licence exclusive portant sur PREOB® au Japon Li...

Asahi Kasei and Bluestar Studying mPPE

Japan’s Asahi Kasei and China’s Bluestar, a ChemChina subsidiary, have agreed to study the economics of building production facilities for producing a modified polyphenylene ether (mPPE) i...

Artisan Draws Strength from Japan and the US to Treat Sepsis

Filmed at the BIO conference in San Diego, Fintan Walton talks to President and Chief Executive Officer of Artisan Pharma, Jeffrey D. Wager MD. Dr Jeffrey reveals how building close, long term relat...

Asahi Kasei Pharma Corp Strategic SWOT Analysis Review [Report Updated: 18072017] Prices from USD $125

Asahi Kasei Pharma Corp Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detail...

Zoll Announces Jury Verdict in Zoll/Philips Patent Dispute

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that a federal jury in Boston awarded it...

Bone Therapeutics And Asahi Kasei Corporation Sign Exclusive License Agreement For PREOB In Japan

  Life Sciences Jobs   ...

Asahi Develops CO2 Route to Diphenyl Carbonate

Japan’s Asahi Kasei has developed a new and safer route to produce diphenyl carbonate (DPC), using carbon dioxide (CO2) as a feedstock instead of phosgene, which is highly toxic. DPC is a feedst...

Asahi Kasei obtains license for bone cell therapy product

Belgium’s Bone Therapeutics (Euronext Brussels: BOTHE) has signed a license agreement granting Japanese…

PubMed Articles [28 Associated PubMed Articles listed on BioPortfolio]

Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.

Electric conductivity in plasma is the balance between oxidized and reduced molecules (static Oxidation-Reduction Potential, sORP) and the amount of readily oxidizable molecules (capacity ORP, cORP). ...

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Variations in Oxidative Stress Levels in 3 Days Follow-up in Ultramarathon Mountain Race Athletes.

Spanidis, Y, Stagos, D, Orfanou, M, Goutzourelas, N, Bar-or, D, Spandidos, D, and Kouretas, D. Variations in oxidative stress levels in 3 days follow-up in ultramarathon mountain race athletes. J Stre...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

Clinical Trials [76 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of Asahi ViE Dialyzer in Canada

The purpose of the study is to obtain performance data on the Asahi ViE-21 dialyzer (ViE-21) .

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [761 Associated Companies listed on BioPortfolio]

Asahi Kasei Pharma Corp.

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care ...

Asahi Kasei Pharma America

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care ...

Asahi Kasei Corporation

Asahi Kasei Corporation, with consolidated sales of US$10 billion, provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, con...

Sankyo Kasei Co., Ltd.

Maeda Chemical Industry Co. merged with Asahi Chemical Industry Co. to establish Sankyo Kasei Co.Capital: ¥30 millionCapital increase: ¥50 million Sodium hydrosulfide plant completed (Akitsu Plant) ...

Rakuto Kasei Ltd

Rakuto Kasei(Israel) Ltd. was established in 1990 as a joint venture with Rakuto Kasei Industrial Co. Japan, a leading worldwide producer of enzymes. Based on over 20 years of experience in the field ...

More Information about "Asahi Kasei Pharma Corp." on BioPortfolio

We have published hundreds of Asahi Kasei Pharma Corp. news stories on BioPortfolio along with dozens of Asahi Kasei Pharma Corp. Clinical Trials and PubMed Articles about Asahi Kasei Pharma Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Asahi Kasei Pharma Corp. Companies in our database. You can also find out about relevant Asahi Kasei Pharma Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...


Corporate Database Quicklinks



Searches Linking to this Company Record